000 | 01835 a2200517 4500 | ||
---|---|---|---|
005 | 20250517233641.0 | ||
264 | 0 | _c20191129 | |
008 | 201911s 0 0 eng d | ||
022 | _a1399-0012 | ||
024 | 7 |
_a10.1111/ctr.13388 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPatel, Yuval A | |
245 | 0 | 0 |
_aThe impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. _h[electronic resource] |
260 |
_bClinical transplantation _c10 2018 |
||
300 |
_ae13388 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCholangitis, Sclerosing _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 |
_aHLA Antigens _ximmunology |
650 | 0 | 4 |
_aHepatitis, Autoimmune _ximmunology |
650 | 0 | 4 |
_aHistocompatibility _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Cirrhosis, Biliary _ximmunology |
650 | 0 | 4 | _aLiver Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSerotyping |
650 | 0 | 4 |
_aTissue Donors _xsupply & distribution |
650 | 0 | 4 | _aTissue and Organ Procurement |
700 | 1 | _aHenson, Jacqueline B | |
700 | 1 | _aWilder, Julius M | |
700 | 1 | _aZheng, Jiayin | |
700 | 1 | _aChow, Schein-Chung | |
700 | 1 | _aBerg, Carl L | |
700 | 1 | _aKnechtle, Stuart J | |
700 | 1 | _aMuir, Andrew J | |
773 | 0 |
_tClinical transplantation _gvol. 32 _gno. 10 _gp. e13388 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ctr.13388 _zAvailable from publisher's website |
999 |
_c28757963 _d28757963 |